SINO BIOPHARM (01177.HK) +0.380 (+5.901%) Short selling $140.31M; Ratio 13.153% opened up 5.49% today and once peaked at HKD6.72. It last printed at HKD6.49, up 1.88%, on a volume of 108 million shares, involving HKD705 million.The company has announced an acquisition of the remaining 95.09% stake in LaNova Medicines to make it its wholly owned subsidiary for a consideration not exceeding USD950 million.Related NewsM Stanley: SINO BIOPHARM (01177.HK) Transaction Price of LaNova UndemandingIn response to market rumors saying that LaNova Medicines has encountered issues with its licensing collaboration with pharmaceutical giant Merck & Co. on the PD-1/VEGF bispecific antibody LM-299, and that the deal may have been called off, SINO BIOPHARM clarified that their partnership is still proceeding in an orderly manner according to the licensing agreement.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-17 12:25.)